United States - English - NLM (National Library of Medicine)

phoenix pharmaceutical, inc. - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - neomycin sulfate 3.5 mg in 1 g - for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists. ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of steroid use in certain cases of infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical radiation or thermal burns; or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. the particular anti-infective drugs in this product is active against the following common bacterial eye pathogens: staphylococcus aureus, escherichia coli, haemophilus influenzae, klebsiella/ente

United States - English - NLM (National Library of Medicine)

direct rx - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - neomycin 3.5 mg in 1 ml - for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists. ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitis is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns, or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. the particular anti-infective drug in this product is active against the following common bacterial eye pathogens: staphylococcus aureus,escherichia coli, haemophilus influenzae, klebsiella/enterobacter spec

United States - English - NLM (National Library of Medicine)

med-pharmex, inc - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297) - neomycin 50 g in 100 g - (neomycin sulfate) antibacterial caution: federal law restricts this drug to use by or on the order of a licensed veterinarian. approved by fda under anada # 200-235 for the treatment and control of colibacillosis (bacterial enteritis) caused by escherichia coli   susceptible to neomycin sulfate in cattle (excluding veal calves), swine, sheep and goats. net weight: 50 lb. (22.6 kg) - - each pound contains:  325 gm neomycin sulfate equivalent to 227.5 gm neomycin. net wt.: 3.5 oz (100g) - -  each packet contains: 71.5 gm neomycin sulfate equivalent to 50 gm neomycin. restricted drug – use only as directed (california) for oral use in animals only - add to drinking water – not for use in liquid supplements

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

allied animal health pty ltd - neomycin base (as the sulfate) - oral powder, pre-mix - neomycin base (as the sulfate) antibiotic active 1000.0 g/kg - antibiotic & related - cattle | pigs | poultry | beef | boar | bos indicus | bos taurus | bovine | breeders | broiler | buffalo | bull | bullock | calf - scours | selenium responsive scours

Canada - English - Health Canada

huvepharma eood - neomycin (neomycin sulfate) - powder for solution - 500mg - neomycin (neomycin sulfate) 500mg - cattle; swine (pigs); poultry; poultry; poultry; horses; sheep

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

jurox pty limited - neomycin sulfate; hydrocortisone - topical cream, ointment, paste, gel, lotion - neomycin sulfate antibiotic active 5.0 mg/g; hydrocortisone steroid-glucocorticoid active 5.0 mg/g - dermatological preps. - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - antibiotic - anti-infective | abrasions | abscesses | airsacculitis | antiseptic | avian mycoplasmas | blackhead | body odours | bowed tendons | broad spectrum | burns | coccidiosis | coliform complex | conjunctivitis | cowpox | cracks | crusts | dandruff | dermatological disorders | dermatosis | dry skin | dysentery | eczema | endometritis | enteric diseases | enzootic pneumonia | feed efficiency | fungal infections | girth galls | infections | inflammed pads | itching | keratolytic | lacerations | mastitis | mycoplasmas | odours | open wounds | otitis | pruritis | queensland itch | respiratory disease | saddle rash | salmonellosis | scabs | scaly skin | sheath rot | skin irritations | sores | swine dysentery | teat cracking | teat infections | topical infections | udder sores | weight gain | wire cuts | wounds

United States - English - NLM (National Library of Medicine)

major pharmaceuticals - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297) - neomycin sulfate 3.5 mg in 1 g

United States - English - NLM (National Library of Medicine)

compania internacional de comercio, s.a.p.i de c.v. - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297) - neomycin 3.5 mg in 1 g - first aid to help prevent infection in minor cuts, scrapes, and burns.

United States - English - NLM (National Library of Medicine)

huvepharma, inc. - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297) - neomycin 0.715 g in 1 g - for the treatment and control of colibacillosis (bacterial enteritis) caused by escherichia coli susceptible to neomycin sulfate in cattle (excluding veal calves), swine, sheep and goats. for the control of mortality associated with escherichia coli organisms susceptible to neomycin sulfate in growing turkeys. each packet contains: 71.5 gm neomycin sulfate equivalent to 50 gm neomycin. for the treatment and control of colibacillosis (bacterial enteritis) caused by escherichia coli susceptible to neomycin sulfate in cattle (excluding veal calves), swine, sheep and goats. for the control of mortality associated with escherichia coli organisms susceptible to neomycin sulfate in growing turkeys. each packet contains: 1430 gm neomycin sulfate equivalent to 1000 gm neomycin. for the treatment and control of colibacillosis (bacterial enteritis) caused by escherichia coli susceptible to neomycin sulfate in cattle (excluding veal calves), swine, sheep and goats. for the control of mortality associated

United States - English - NLM (National Library of Medicine)

bimeda, inc. - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297) - neomycin 227.5 g in 0.454 kg - neomed® 325 (neomycin sulfate ) commercial grade for oral use in cattle, swine, sheep, goats & turkeys for the treatment and control of colibacillosis (bacterial enteritis) caused by escherichia coli susceptible to neomycin sulfate in cattle (excluding veal calves), swine, sheep and goats . for the control of mortality associated with escherichia coli organisms susceptible to neomycin sulfate in growing turkeys. antibacterial caution: federal law restricts this drug to use by or on the order of a licensed veterinarian. each pound contains:  325 g neomycin sulfate (commercial grade) equivalent to 227.5 g neomycin. not for use in humans keep out of reach of children restricted drug (california)- use only as directed anada 200-050, approved by fda net weight: 50 pounds (22.7 kg)